Want to see UHS full AI Analyst Report?
UHS Stock Chart & Stats
$182.41
$2.61(1.40%)
At close: 4:00 PM EST
$182.41
$2.61(1.40%)
Day’s Range― - ―
52-Week Range$140.08 - $246.33
Previous CloseN/A
Volume143.67K
Average Volume (3M)943.48K
Market Cap
$8.73B
Enterprise Value$13.85B
Total Cash (Recent Filing)$119.03M
Total Debt (Recent Filing)$5.13B
Price to Earnings (P/E)6.1
Beta0.51
Next Earnings
Jul 27, 2026EPS Estimate
5.94Next Dividend Ex-DateN/A
Dividend Yield0.35%
Share Statistics
EPS (TTM)24.14
Shares Outstanding53,287,605
10 Day Avg. Volume747,768
30 Day Avg. Volume943,484
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.91
Price to Sales (P/S)0.80
P/FCF Ratio16.32
Enterprise Value/Market Cap1.59
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit1.09
Enterprise Value/Ebitda4.95
Forecast
1Y Price Target
$206.00Price Target Upside12.93% Upside
Rating ConsensusHold
Number of Analyst Covering14
EPS Forecast (FY)23.45
Revenue Forecast (FY)$18.53B
Bulls Say, Bears Say
Bulls Say
Strong Profitability & ROEUHS demonstrates durable operating profitability with a TTM ROE near 21% and mid‑teens EBITDA margins. These margins provide structural capacity to absorb reimbursement pressure, fund incremental investments and support returns to shareholders, underpinning resilience over the next 2–6 months.
Consistent Cash Generation & BuybacksPositive and recurring operating cash flow and meaningful free cash flow enable sustained capital returns and reinvestment. Ongoing aggressive buybacks (target $800–$900M annually, $1.3B authorization) plus capacity to fund capex give management flexibility to allocate cash to strategic priorities over the medium term.
Talkspace Deal & Digital ExpansionAcquiring Talkspace materially accelerates UHS’s virtual outpatient footprint and bidirectional care pathways. Expected near‑term accretion and targeted low single‑digit EBITDA multiple by year three suggest structural capability to scale virtual behavioral care, diversify revenue streams and capture higher-margin outpatient demand.
Bears Say
Health Insurance Exchange (HIX) HeadwindMaterial HIX exposure creates structural revenue and bad‑debt risk if exchange enrollment or premium payment behavior deteriorates. A conservatively reserved $75M pretax hit reduces operating income and raises uncertainty around payer mix and collectability, pressuring margins persistently until enrollment stabilizes.
Behavioral Staffing & Wage PressureOngoing elevated wage growth and continued turnover in behavioral health compress margins in UHS’s strategically important segment. Even with improvement from prior years, sustained labor cost inflation requires ongoing operational fixes and could blunt margin gains from outpatient expansion or M&A integration over the medium term.
Cash Conversion Volatility & Meaningful DebtFree cash flow materially below net income signals working‑capital swings and conversion volatility. Combined with meaningful absolute debt levels, this can constrain flexibility for M&A, buybacks or downside shocks. Leverage rising modestly with the Talkspace deal increases sensitivity to operating variation over the next several quarters.
UHS FAQ
What was Universal Health’s price range in the past 12 months?
Universal Health lowest stock price was $140.08 and its highest was $246.32 in the past 12 months.
What is Universal Health’s market cap?
Universal Health’s market cap is $8.73B.
When is Universal Health’s upcoming earnings report date?
Universal Health’s upcoming earnings report date is Jul 27, 2026 which is in 11 days.
How were Universal Health’s earnings last quarter?
Universal Health released its earnings results on Apr 27, 2026. The company reported $5.62 earnings per share for the quarter, beating the consensus estimate of $5.409 by $0.211.
Is Universal Health overvalued?
According to Wall Street analysts Universal Health’s price is currently Undervalued.
Does Universal Health pay dividends?
Universal Health pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.35%. See more information on Universal Health dividends here
What is Universal Health’s EPS estimate?
Universal Health’s EPS estimate is 5.94.
How many shares outstanding does Universal Health have?
Universal Health has 53,287,605 shares outstanding.
What happened to Universal Health’s price movement after its last earnings report?
Universal Health reported an EPS of $5.62 in its last earnings report, beating expectations of $5.409. Following the earnings report the stock price went down -9.453%.
Which hedge fund is a major shareholder of Universal Health?
Currently, no hedge funds are holding shares in UHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Universal Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$206.00 (12.93% Upside)
$206.00 (12.93% Upside)
Blogger Sentiment
Bullish
UHS Sentiment 70%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 92.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 6.4%
Last 30 Days ▲ 6.4%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.04%
12-Months-Change
Fundamentals
Return on Equity
20.93%
Trailing 12-Months
Asset Growth
5.42%
Trailing 12-Months
Company Description
Universal Health
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.
UHS Net revenue Breakdown
9.61% Medicare
10.85% Managed Medicare
12.97% Medicaid
13.27% Managed Medicaid
25.89% Managed Care (HMO and PPOs)
5.07% UK Revenue
6.41% Other patient revenue and adjustments, net
7.08% Other non-patient revenue

UHS Stock 12 Month Forecast
Average Price Target
$206.00
▲(12.93% Upside)
Technical Analysis
Ownership Overview
6.01% Insiders
31.36% Mutual Funds
0.25% Other Institutional Investors
32.23% Public Companies and
Individual Investors










